About Alliqua
Alliqua is a company based in Yardley (United States) founded in 1997.. Alliqua has completed 2 acquisitions, including Celleration and Choice Therapeutics. Alliqua offers products and services including Custom Hydrogels and Hydrogel Manufacturing Platform. Alliqua operates in a competitive market with competitors including scPharmaceuticals, Crossject, Valeritas, CeQur and Vaxxas, among others.
- Headquarter Yardley, United States
- Stage Public
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Alliqua Biomedical, Inc.
-
Annual Revenue
$2.22 M10as on Dec 31, 2018
-
Net Profit
$-8.42 M67as on Dec 31, 2018
-
EBITDA
$-5.3 M-11as on Dec 31, 2018
-
Latest Funding Round
$2.77 M (USD), Post-IPO
Mar 13, 2017
- Investors
-
Employee Count
Employee Count
-
Investments & Acquisitions
Celleration
& 1 more
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Alliqua
Alliqua offers a comprehensive portfolio of products and services, including Custom Hydrogels and Hydrogel Manufacturing Platform. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Hydrogels for wound healing and skin care delivery
Platform for electron-beam cross-linked gels in healthcare
Unlock access to complete
Unlock access to complete
Funding Insights of Alliqua
- Total Funding Total Funding
- Total Rounds 15
- Last Round Post-IPO — $2.8M
-
First Round
First Round
(25 May 2010)
- Investors Count 1
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Mar, 2017 | Amount | Post-IPO - Alliqua | Valuation |
investors |
|
| Jun, 2016 | Amount | Debt – Conventional - Alliqua | Valuation |
investors |
|
| May, 2015 | Amount | Debt – Conventional - Alliqua | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Alliqua
Alliqua has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include Perceptive Advisors. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Health-tech companies are targeted for venture capital investments.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Alliqua
Alliqua has strategically engaged in corporate development activities, having acquired 2 companies. Notable acquisitions include Celleration and Choice Therapeutics. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Wound care products for burns and surgical infections are manufactured.
|
2006 | ||||
|
Ultrasound technology for wound healing is developed and marketed.
|
1999 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
OVO is recognized as a smart digital payment application.
|
2017 | ||||
|
Bionic investment advisor platform
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 |
Financial Statements - Alliqua
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Alliqua Comparisons
Competitors of Alliqua
Alliqua operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as scPharmaceuticals, Crossject, Valeritas, CeQur and Vaxxas, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Provider of a device for subcutaneous drug delivery for the treatment of bacterial infections and heart failure
|
|
| domain | founded_year | HQ Location |
Needle-free self-injectable drugs
|
|
| domain | founded_year | HQ Location |
Wearable insulin patch pumps are developed for transdermal delivery.
|
|
| domain | founded_year | HQ Location |
Wearable insulin delivery patches are developed for mealtime dosing.
|
|
| domain | founded_year | HQ Location |
Developer of vaccines to treat cancer and infectious diseases
|
|
| domain | founded_year | HQ Location |
Hospital-focused specialty pharmaceuticals are developed for acute pain management.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Alliqua
Frequently Asked Questions about Alliqua
When was Alliqua founded?
Alliqua was founded in 1997 and raised its 1st funding round 13 years after it was founded.
Where is Alliqua located?
Alliqua is headquartered in Yardley, United States. It is registered at Yardley, Pennsylvania, United States.
What is the annual revenue of Alliqua?
Annual revenue of Alliqua is $2.22M as on Dec 31, 2018.
What does Alliqua do?
Alliqua was founded in 1997 as a biomedical company based in Yardley, United States. Operations focus on the development, manufacturing, and marketing of proprietary wound care products, including SilverSeal Hydrogel for antimicrobial applications and Hydress for moist wound management. A core transdermal delivery platform is utilized to enable drug and ingredient absorption through the skin, supporting advancements in the healthcare sector.
Who are the top competitors of Alliqua?
Alliqua's top competitors include scPharmaceuticals, Crossject and Vaxxas.
What products or services does Alliqua offer?
Alliqua offers Custom Hydrogels and Hydrogel Manufacturing Platform.
How many acquisitions has Alliqua made?
Alliqua has made 2 acquisitions, including Celleration, and Choice Therapeutics.
Who are Alliqua's investors?
Alliqua has 1 investor. Key investors include Perceptive Advisors.